Endothelin antagonism in pulmonary hypertension, heart failure, and beyond.
Attinà
T
T
Clinical Research Centre, Department of Medical Sciences, University of Edinburgh, Edinburgh, UK.
Camidge
R
R
Newby
D E
DE
Webb
D J
DJ
D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000502:physiology; D000072396:Endothelin-Converting Enzymes; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D017466:Receptors, Endothelin / Q000145:classification
D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D017466:Receptors, Endothelin; D016282:Aspartic Acid Endopeptidases; D008666:Metalloendopeptidases; D000072396:Endothelin-Converting Enzymes